Gilead Sciences

Open: 77.54 Close: 76.62 Change: -0.92

What an AI can tell you about Gilead Sciences Stock before investing.

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, NASDAQGILD, A, Is, Paying, Larger, …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences (NASDAQ:GILD) Is Paying Out A Larger Dividend Than Last Year. The company has been growing its dividend at a decent rate, and the payments have been stable. Geode Capital Management LLC led the pack by a hairline.

Today's News

Gilead Sciences (NASDAQ:GILD) Is Paying Out A Larger Dividend Than Last Year. The company has been growing its dividend at a decent rate, and the payments have been stable. We think this could be an attractive income stock. Gilead Sciences (NASDAQ:GILD) Is Paying Out A Larger Dividend Than Last Year. The European Commission (EC) will review the CHMP recommendation and, if adopted, Veklury will become the first and only authorized antiviral COVID-19. Gilead Sciences, Inc. (NASDAQ:GILD) Generates Positive Market Sentiment despite Q4 Earnings Miss - Best Stocks Best stocks to buy now. Geode Capital Management LLC led the pack by a hairline, raising its position in Gilead Sciences by 1.0% during Q4 2020. BI Asset Management Fondsmaeglerselskab A S raised its stakes by an astounding 422.1%. Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, manufactures, and commercializes therapies for viral diseases, infectious diseases, and cancer. The Human Rights Campaign (HRC) is proud to announce the expansion of its work -- supported by a three-year, $5 million grant.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

Are looking for the most relevant information about Gilead Sciences? Investor spend a lot of time searching for information to make investment decisions in Gilead Sciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, NASDAQGILD, A, Is, Paying, Larger, and the most common words in the summary are: gilead, science, stock, report, street, option, price, . One of the sentences in the summary was: The company has been growing its dividend at a decent rate, and the payments have been stable. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #stock #report #street #option #price.